Research, Science & Development

Neuralink’s clinical programme has recorded notable early milestones, including reports that its first human participant successfully operated a computer and typed using neural signals alone.

Insulet received Investigational Device Exemption approval from the U.S. Food and Drug Administration in March 2026, clearing the way for the trial to begin.

The study found that resistance to commonly prescribed antibiotics, including ampicillin and cotrimoxazole, now exceeds 90% in some wound infection cases.

The study suggests that tracking sleep patterns before rehabilitation begins could help healthcare teams identify patients who may need extra support to stay engaged throughout treatment.

AI Platform Accelerates Development Timeline
The team developed ISM0387 using Insilico Medicine’s Chemistry42 platform, which integrates more than 40 generative AI models to analyse complex biological and chemical data.

The study showed that oral semaglutide achieved a significantly greater reduction in HbA1c levels, a key marker of blood sugar control, compared to placebo.

The summit convenes senior executives from healthcare, biotechnology, artificial intelligence, academia, and investment firms under the theme “Healthtech Frontiers: Building the Health Ecosystem of Tomorrow.”

Less than 10% of participants in the Nuvaxovid group experienced severe side effects that interfered with daily activities compared with 20% in the mNexspike group.

Three Moscow hospitals tested the system and achieved strong results: the algorithm identified quality problems with 94% accuracy and detected data errors in 99% of cases.

The work centres on magnetic resonance imaging (MRI), a widely used diagnostic tool that allows doctors to visualise tumours inside the body.